GENOTROPIN

This brand name is authorized in Albania, Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, UK.

Active ingredients

The drug GENOTROPIN contains one active pharmaceutical ingredient (API):

1	Recombinant human recombinant UNII NQX9KB6PCL - SOMATROPIN
	Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat.
	Read more about Somatropin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GENOTROPIN Powder and solvent for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AC01	Somatropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	504/96
AU	Pharmaceutical Benefits Scheme	10426R, 10428W, 10430Y, 10431B, 10434E, 10435F, 10443P, 10453E, 10454F, 10456H, 10457J, 10463Q, 10472E, 10477K, 10479M, 10480N, 10488B, 10498M, 10500P, 10501Q, 10891F, 10902T, 10908D, 11493X, 11495B, 6313G, 6314H, 6315J, 6316K, 6317L, 6318M, 6319N, 9585L, 9586M, 9628R
BR	Câmara de Regulação do Mercado de Medicamentos	522720050086617, 522720050086717, 522720050086817, 522720050086917, 522720050087017, 522720050087117
CA	Health Products and Food Branch	02401703, 02401711, 02401746, 02401754, 02401762, 02401770, 02401789, 02401797, 02401800, 02401819, 02401827, 02401835
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	112-MBE-0917, 113-MBE-0917
EE	Ravimiamet	1022072, 1041185, 1064281
FI	Lääkealan turvallisuus- ja kehittämiskeskus	096603, 096614
GB	Medicines & Healthcare Products Regulatory Agency	182734, 182741, 37894, 37898, 47725, 47730, 48974, 49415, 49418, 49489, 49509, 49521, 49554, 49558
HK	Department of Health Drug Office	35414
HR	Agencija za lijekove i medicinske proizvode	HR-H-271559549, HR-H-283274235, HR-H-358647692, HR-H-812600746
IE	Health Products Regulatory Authority	88068, 88069, 88070, 88071, 88072, 88073, 88074, 88301, 88302, 88303, 88527, 88528
IL	מִשְׂרַד הַבְּרִיאוּת	4041, 4042, 8385, 8386
JP	医薬品医療機器総合機構	2412402D9038, 2412402L4057, 2412402P4024, 2412402P5020
LT	Valstybinė vaistų kontrolės tarnyba	1002620, 1002893, 1015108, 1015292, 1060316, 1060317, 1060318, 1060319
MT	Medicines Authority	MA505/00901
NL	Z-Index G-Standaard	14607557, 14607573
NL	Z-Index G-Standaard, PRK	35122, 57789
NZ	Medicines and Medical Devices Safety Authority	4724, 4725, 4731, 8423, 8424, 8425, 8426, 8427, 8428, 8429, 8430, 8431, 9898
PL	Rejestru Produktów Leczniczych	100026284, 100081515
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64823001, W64823002, W64823003, W64823004
SG	Health Sciences Authority	05273P
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308957795, 8681308957801